Trial · NCT03541603
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline Pulmonary Capillary Wedge Pressure (PCWP) With Bicycle Exercise | Levosimendan 2.5mg/mL Injectable Solution | -1.9 | Standard Deviation 10.07 | mmHg | |
| Change From Baseline Pulmonary Capillary Wedge Pressure (PCWP) With Bicycle Exercise | Matching Placebo | -0.5 | Standard Deviation 7.87 | mmHg | |
| Change in Cardiac Index (CI) at Rest and With Exercise. | Levosimendan 2.5mg/mL Injectable Solution | rest | 0.05 | Standard Deviation 0.699 | L/min/m^2 |
| Change in Cardiac Index (CI) at Rest and With Exercise. | Matching Placebo | rest | -0.15 | Standard Deviation 0.262 | L/min/m^2 |
| Change in Cardiac Index (CI) at Rest and With Exercise. | Levosimendan 2.5mg/mL Injectable Solution | exercise | 0.24 | Standard Deviation 1.106 | L/min/m^2 |
| Change in Cardiac Index (CI) at Rest and With Exercise. | Matching Placebo | exercise | 0.04 | Standard Deviation 0.594 | L/min/m^2 |
| Change in Pulmonary Vascular Resistance (PVR) Effect at Rest and With Exercise | Levosimendan 2.5mg/mL Injectable Solution | rest | -0.09 | Standard Deviation 1.050 | mmHg.min/L |
| Change in Pulmonary Vascular Resistance (PVR) Effect at Rest and With Exercise | Matching Placebo | rest | 0.15 | Standard Deviation 2.238 | mmHg.min/L |
| Change in Pulmonary Vascular Resistance (PVR) Effect at Rest and With Exercise | Levosimendan 2.5mg/mL Injectable Solution | exercise | -0.44 | Standard Deviation 1.539 | mmHg.min/L |
| Change in Pulmonary Vascular Resistance (PVR) Effect at Rest and With Exercise | Matching Placebo | exercise | -0.16 | Standard Deviation 1.81 | mmHg.min/L |
| Change in PCWP When Supine and Legs Elevated | Levosimendan 2.5mg/mL Injectable Solution | rest | -5.1 | Standard Deviation 5.26 | mmHg |
| Change in PCWP When Supine and Legs Elevated | Matching Placebo | rest | -1.7 | Standard Deviation 6.14 | mmHg |
| Change in PCWP When Supine and Legs Elevated | Levosimendan 2.5mg/mL Injectable Solution | legs elevated | -6.0 | Standard Deviation 7.75 | mmHg |
| Change in PCWP When Supine and Legs Elevated | Matching Placebo | legs elevated | -0.3 | Standard Deviation 5.45 | mmHg |
| Patient Global Assessment | Levosimendan 2.5mg/mL Injectable Solution | 3 | Inter-Quartile Range 3 to 4 | units on a scale | |
| Patient Global Assessment | Matching Placebo | 3 | Inter-Quartile Range 3 to 4 | units on a scale | |
| Exercise Duration Via 6 Minute Walk Test | Levosimendan 2.5mg/mL Injectable Solution | 16.6 | Standard Deviation 40.03 | meters | |
| Exercise Duration Via 6 Minute Walk Test | Matching Placebo | -12.8 | Standard Deviation 35.08 | meters | |
| Physician's Assessment of Functional Class | Levosimendan 2.5mg/mL Injectable Solution | Baseline / Class I | 0 | Participants | |
| Physician's Assessment of Functional Class | Matching Placebo | Baseline / Class I | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03541603/results